XML 92 R71.htm IDEA: XBRL DOCUMENT v3.21.2
Segment Information - Summary of Net Sales and Operating Profit by Segment (Detail) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Net Sales And Operating Profit Information [Line Items]        
Net Sales $ 2,026.9 $ 1,226.1 $ 3,874.3 $ 3,009.9
Operating Profit (Loss) 220.5 (171.7) 486.1 (627.7)
Intangible asset amortization (154.6) (147.7) (310.1) (295.3)
Goodwill and intangible asset impairment (16.3) (33.0) (16.3) (645.0)
Restructuring and other cost reduction initiatives (19.6) (28.0) (41.4) (73.0)
Quality remediation (11.0) (9.7) (21.2) (26.1)
Acquisition, integration, divestiture and related (25.4) (2.2) (38.8) (6.6)
EMEA [Member]        
Net Sales And Operating Profit Information [Line Items]        
Net Sales 429.8 218.7 814.0 616.8
Asia Pacific [Member]        
Net Sales And Operating Profit Information [Line Items]        
Net Sales 357.5 273.7 705.7 558.1
Corporate Functions [Member]        
Net Sales And Operating Profit Information [Line Items]        
Operating Profit (Loss) (162.0) (229.0) (318.4) (393.4)
Operating Segments [Member] | Americas Orthopedics [Member]        
Net Sales And Operating Profit Information [Line Items]        
Net Sales 1,058.3 626.5 2,004.5 1,569.5
Operating Profit (Loss) 445.4 203.7 832.5 607.0
Operating Segments [Member] | EMEA [Member]        
Net Sales And Operating Profit Information [Line Items]        
Net Sales 392.9 204.1 742.0 575.4
Operating Profit (Loss) 95.2 20.1 181.5 128.9
Operating Segments [Member] | Asia Pacific [Member]        
Net Sales And Operating Profit Information [Line Items]        
Net Sales 345.7 264.5 682.6 540.4
Operating Profit (Loss) 111.4 78.4 231.7 171.0
Operating Segments [Member] | Americas Spine and Global Dental [Member]        
Net Sales And Operating Profit Information [Line Items]        
Net Sales 230.0 131.0 445.2 324.6
Operating Profit (Loss) 40.1 (3.4) 79.1 22.5
Segment Reconciling Items [Member]        
Net Sales And Operating Profit Information [Line Items]        
Inventory and manufacturing-related charges (7.9) (1.4) (2.0) (2.0)
Intangible asset amortization (154.6) (147.7) (310.1) (295.3)
Goodwill and intangible asset impairment (16.3) (33.0) (16.3) (645.0)
Restructuring and other cost reduction initiatives (19.7) (28.0) (41.6) (73.0)
Quality remediation (11.0) (9.9) (21.2) (25.8)
Acquisition, integration, divestiture and related (25.4) (2.2) (38.8) (6.6)
Litigation (3.6) (1.3) (9.7) (81.1)
European Union Medical Device Regulation (10.6) (6.1) (17.5) (17.1)
Certain R&D agreements (65.0)   (65.0)  
Other charges $ 4.5 $ (11.9) $ 1.9 $ (17.8)